Loading...
NPI 1649829987 · Colorado Springs, CO · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Centennial State Lab, LLC is a clinical medical laboratory provider located in Colorado Springs, Colorado. This profile covers 26 Medicare and 63 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Centennial State Lab, LLC |
| Address | 4775 Centennial Blvd Ste 120 |
| City | Colorado Springs |
| State | CO |
| ZIP | 80919 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 10, 2019 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $33.1M |
| Medicare | $1.4M |
CENTENNIAL STATE LAB, LLC is heavily Medicaid-weighted: lifetime Medicaid revenue is $33.1M compared with $1.4M in Medicare, indicating the provider operates at a markedly larger scale on state programs than on Medicare. This suggests the lab’s commercial positioning and client base are primarily driven by Medicaid contracts or referral networks rather than by Medicare volume.
The provider’s service mix is dominated by molecular and high-throughput infectious-disease testing: Medicare and Medicaid top codes are concentrated in amplified nucleic acid probe techniques and multiplex respiratory panels (examples include 87798, 87631, 87633, U0003 and U0005). In addition, definitive drug testing codes (G0483/G0482) and a range of sexually transmitted infection assays (87481, 87591, 87511) appear in the top lists, painting a picture of a clinical laboratory focused on molecular diagnostics, infectious disease surveillance, STI testing and toxicology.
Medicare revenue is concentrated in a very small set of assays: the top 3 Medicare codes account for 72.3% of total Medicare revenue, with 87798 alone contributing $732.1K (52.8% of Medicare revenue). This concentration indicates that a few molecular assays are the primary drivers of the lab’s Medicare receipts, making Medicare exposure dependent on a limited procedure set.
On Medicaid the lab also shows strong revenue concentration: the precomputed top-3 Medicaid codes account for 60.3% of Medicaid revenue, driven primarily by 87798 ($12M, 37.2%), 87631 ($3.9M, 12.2%) and U0003 ($3.5M, 10.8%). Those three codes together form the backbone of the lab’s Medicaid business, reflecting a focus on high-volume infectious-agent and respiratory-panel testing for state patients.
CENTENNIAL STATE LAB is a dominant in-state player for molecular testing: multiple Medicaid codes rank at the top of Colorado peers (87798, 87631, 87633, 87640 and others are ranked #1 in-state and labeled as “extreme outlier, far above typical state volume for this code”). This statewide dominance for core molecular assays implies the lab is a major testing hub in Colorado, likely handling large centralized volumes that smaller in-state labs do not.
By contrast, the provider’s national standing on Medicare is mixed: 87798 ranks #82 of 1319 nationally (94th percentile) and 87631 ranks #34 of 636 (95th percentile), but many Medicare top-line codes are described as “typical, unremarkable volume for this code.” In practice this means the lab registers notable national placement on specific molecular codes yet still reflects modest absolute Medicare scale ($1.4M total) compared with its Medicaid footprint.
The presence and volume of high-throughput SARS-CoV-2 and multiplex respiratory testing are notable operational signals: U0003 (high-throughput SARS-CoV-2) appears with $3.5M Medicaid revenue and 47.8K Medicaid claims (rank #2 in-state, 99th percentile) and U0005 appears as a top Medicaid code as well. These entries, together with 87635 and 87631 in Medicare and Medicaid top lists, indicate sustained investment or capacity in rapid, high-volume molecular testing workflows.
The NPI has been enumerated since 2019-09-10 (~7 years ago), which provides a relatively recent but multi-year operating history; combined with the concentrated Medicaid dominance and high volumes on molecular panels, the profile suggests rapid scale-up of state-facing molecular services in a short window. For payers and competitors, this tenure plus the extreme in-state volumes signals a mature service-line focus despite limited Medicare revenue scale.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 21,530 | $30 | $732.1K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 4,310 | $30 | $146.5K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 880 | $140 | $123.8K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 2,140 | $30 | $72.8K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 1,240 | $30 | $42.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 840 | $50 | $42.2K |
| 87486 | The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild… | 1,070 | $30 | $36.3K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 960 | $30 | $32.5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 440 | $70 | $32.2K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 120 | $240 | $27.8K |
Showing 1–10 of 26
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
63 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 58,360 | $210 | $12M |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 31,170 | $130 | $3.9M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 47,760 | $70 | $3.5M |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 8,400 | $370 | $3.1M |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 45,990 | $30 | $1.4M |
| 87486 | The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild… | 37,700 | $30 | $1.2M |
| 87581 | The lab analyst performs a test for Mycoplasma pneumonia, a bacteria, using amplified nucleic acid probe technique. | 34,920 | $30 | $1.1M |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 9,850 | $90 | $857.2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 36,470 | $20 | $838.9K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 22,470 | $30 | $674.1K |
Showing 1–10 of 63
How this provider's Medicaid billing volume and revenue compare to other Colorado providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Colorado median
63 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 15 | 40 | 900 | $170 | $1.5M |
| 80326 | The lab analyst measures the amount of or detects the presence of five or more amphetamines, a central nervous system stimulant, in a patient specimen. | 2 | 10 | 25,160 | $20 | $386.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 1 | 40 | 110 | $160 | $326K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7 | 10 | 1,620 | $140 | $296.6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 2 | 80 | 830 | $70 | $274.8K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 1 | 20 | 170 | $290 | $242.4K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 15 | 20 | 590 | $30 | $230.4K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 1 | 30 | 170 | $100 | $197.7K |
| 80347 | The lab analyst measures the amount of or detects the presence of 13 or more benzodiazepines, which are tranquilizers, in a patient specimen. | 2 | 10 | 940 | $20 | $185.3K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 10 | 60 | 360 | $30 | $183.5K |
Showing 1–10 of 63
Other providers in the same ZIP code as Centennial State Lab, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.